Fonte: World journal of clinical cases. Unidade: FM
Assuntos: HIV, MIOPATIAS CONGÊNITAS ESTRUTURAIS, REUMATOLOGIA, TERAPÊUTICA
ABNT
GONCALVES JUNIOR, Jucier e SHINJO, Samuel Katsuyuki. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?. World journal of clinical cases, v. 10, n. 4, p. 1454-1456, 2022Tradução . . Disponível em: https://doi.org/10.12998/wjcc.v10.i4.1454. Acesso em: 01 nov. 2024.APA
Goncalves Junior, J., & Shinjo, S. K. (2022). Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? World journal of clinical cases, 10( 4), 1454-1456. doi:10.12998/wjcc.v10.i4.1454NLM
Goncalves Junior J, Shinjo SK. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? [Internet]. World journal of clinical cases. 2022 ; 10( 4): 1454-1456.[citado 2024 nov. 01 ] Available from: https://doi.org/10.12998/wjcc.v10.i4.1454Vancouver
Goncalves Junior J, Shinjo SK. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? [Internet]. World journal of clinical cases. 2022 ; 10( 4): 1454-1456.[citado 2024 nov. 01 ] Available from: https://doi.org/10.12998/wjcc.v10.i4.1454